Results 31 to 40 of about 150,610 (217)

Risk Factors for the Comorbidity of Hypertension and Renal Cell Carcinoma in the Cardio-Oncologic Era and Treatment for Tumor-Induced Hypertension

Frontiers in Cardiovascular Medicine, 2022
Advances in tumor diagnosis and treatment, especially the use of targeted therapies, have remarkably improved the survival rate of patients with renal cell carcinoma (RCC), accompanied by higher hypertension (HTN) incidence among patients with RCC ...
Zhengqing Ba, Ying Xiao, Ying Xiao, Ming He, Dong Liu, Hao Wang, Hanyang Liang, Jiansong Yuan, Jiansong Yuan   +8 more
doaj   +1 more source

Choice of treatment based on Turkish hypertension consensus report: Do we follow the recommendations?

Türk Kardiyoloji Derneği Arşivi, 2018
Objective: The aim of this study was to determine how often the recommendations of the Turkish Hypertension Consensus Report are followed, and to draw attention to the report.
Gülden Yürüyen, İlkim Deniz Toprak, Zeki Toprak, Murat Akarsu, Pınar Demir, Yücel Arman, Eylem Özgün Çil, Mustafa Özcan, Sedat Irmak, Özgür Altun, Şengül Aydın Yoldemir, Hasan Eruzun, Tufan Tükek   +12 more
doaj   +1 more source

Synthesis and Antifungal Activity of 1,2,4-Oxadiazole Derivatives

Molecules
1,2,4-Oxadiazole derivatives containing anisic acid or cinnamic acid were designed and synthesized, which were expected to be an effective Succinate dehydrogenase (SDH) inhibitor, and their structures were characterized by 1H NMR, 13C NMR, and ESI-MS ...
Lili Yu, Kuan Yang, Lin Yao, Nana Wang, Hui Kang, Guangda Yao, Xiaomeng Li, Bei Qin   +7 more
doaj   +1 more source

Outpatient antihypertensive drug utilization in Canton Sarajevo during five years period (2004-2008) and adherence to treatment guidelines assessment

Biomolecules & Biomedicine, 2011
Hypertension is chronic disease with high prevalence, which can successfully be treated with antihypertensive drugs. Previous researches have shown that existing hypertension treatment guidelines are not fully implemented in practice.
Tarik Čatić, Begler Begović
doaj   +1 more source

Impact of COVID-19 epidemic on antihypertensive drug treatment disruptions: results from a nationwide interrupted time-series analysis

Frontiers in Pharmacology, 2023
Background: The COVID-19 epidemic has disrupted care and access to care in many ways. It was accompanied by an excess of cardiovascular drug treatment discontinuations.
Clément Mathieu, Julien Bezin, Julien Bezin, Antoine Pariente, Antoine Pariente   +4 more
doaj   +1 more source

A comparative study of antihypertensive drugs prediction models for the elderly based on machine learning algorithms

Frontiers in Cardiovascular Medicine, 2022
BackgroundGlobally, blood pressure management strategies were ineffective, and a low percentage of patients receiving hypertension treatment had their blood pressure controlled.
Tiantian Wang, Yongjie Yan, Shoushu Xiang, Juntao Tan, Chen Yang, Wenlong Zhao   +5 more
doaj   +1 more source

Effect of Hypertension on Outcomes of High-Risk Patients After BCG-Treated Bladder Cancer [PDF]

, 2015
Immunotherapy with Bacillus Calmette Guerin (BCG) is the most efficacious treatment for high-risk bladder cancer (BC) (Ta/T1 or carcinoma in situ) to reduce the risk of recurrence.
Alberto, Bovo, Alessandro, Crestani, DAL MORO, Fabrizio, Marina P., Gardiman, Roberto, Vettor, Zattoni, Filiberto   +5 more
core   +1 more source

Design, Formulation, and Characterization of Valsartan Nanoethosomes for Improving Their Bioavailability

Pharmaceutics, 2022
The objective of this study was to formulate and evaluate valsartan (VLT) ethosomes to prepare an optimized formula of VLT-entrapped ethosomes that could be incorporated into a sustained release transdermal gel dosage form.
Ali M. Nasr, Fayrouz Moftah, Mohammed A. S. Abourehab, Shadeed Gad   +3 more
doaj   +1 more source

Drug treatment of hypertension: focus on vascular health [PDF]

, 2016
Hypertension, the most common preventable risk factor for cardiovascular disease and death, is a growing health burden. Serious cardiovascular complications result from target organ damage including cerebrovascular disease, heart failure, ischaemic heart
Cameron, Alan C., Lang, Ninian N., Touyz, Rhian M.   +2 more
core   +1 more source

Efficacy, safety and Cardiovascular Disease Risk Lowering Ability of ACE Inhibitors, B-Blockers and Combination Antihypertensive Drug Regimes in Iraq

Iraqi Journal of Pharmaceutical Sciences, 2017
Hypertension is a major health problem throughout the world because of its high prevalence and its association with increased risk of cardiovascular diseases.
Dlveen M. Sulaiman, Kassim J.Al-Shamma, Ansam N.Al-Hassani   +2 more
doaj   +1 more source